Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01288014
What this trial is testing

Cytokine Production and Immunity to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine

Who this might be right for
Immunity; Defect Due to Antibody or Cell Mediated Immune Defect
Columbia University 26
Large-scale testing (Phase 3)UnknownNCT05216484
What this trial is testing

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

Who this might be right for
SARS-CoV-2 Infection
Chinese Academy of Medical Sciences 480
Large-scale testing (Phase 3)Study completedNCT03971370
What this trial is testing

Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine .

Who this might be right for
Adverse Effect and Immunogenicity of Vaccine
Jiangsu Province Centers for Disease Control and Prevention 1,800
Testing effectiveness (Phase 2)Study completedNCT01415011
What this trial is testing

Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University College, London 39
Not applicableStudy completedNCT01755884
What this trial is testing

Oral Desensitization to Wheat in School Aged Children

Who this might be right for
Wheat Allergy
Helsinki University Central Hospital 100
Large-scale testing (Phase 3)Study completedNCT00232934
What this trial is testing

Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients

Who this might be right for
Multiple Myeloma
Gruppo Italiano per lo Studio del Mieloma Multiplo 400
Testing effectiveness (Phase 2)Study completedNCT01930357
What this trial is testing

Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen

Who this might be right for
Rabies
Sanofi Pasteur, a Sanofi Company 342
Large-scale testing (Phase 3)Study completedNCT05107375
What this trial is testing

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 299
Testing effectiveness (Phase 2)Study completedNCT00401492
What this trial is testing

MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
National Cancer Institute, Naples 159
Large-scale testing (Phase 3)Study completedNCT02621177
What this trial is testing

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents

Who this might be right for
Influenza, Human
SK Chemicals Co., Ltd. 385
Testing effectiveness (Phase 2)Study completedNCT00911183
What this trial is testing

Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial

Who this might be right for
Lymphoma
Institut Bergonié 67
Not applicableStudy completedNCT03211702
What this trial is testing

Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2)

Who this might be right for
Lymphoma, Large B-cell, Diffuse
Chonbuk National University Hospital 100
Not applicableStudy completedNCT05972577
What this trial is testing

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more
Ohio State University Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT04796857
What this trial is testing

Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL

Who this might be right for
Non-GCB/ABC Diffuse Large B-Cell LymphomaHigh-grade B-cell LymphomaFollicular Lymphoma Grade IIIb+3 more
Huiqiang Huang 30
Testing effectiveness (Phase 2)Study completedNCT00376467
What this trial is testing

STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 105
Large-scale testing (Phase 3)Study completedNCT01864850
What this trial is testing

Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 202
Large-scale testing (Phase 3)Study completedNCT02892708
What this trial is testing

Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over

Who this might be right for
Malignant Glioma
Assistance Publique - Hôpitaux de Paris 107
Early research (Phase 1)Study completedNCT00392691
What this trial is testing

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Lymphoma
Swiss Cancer Institute 20
Large-scale testing (Phase 3)Study completedNCT01148446
What this trial is testing

R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL

Who this might be right for
Elderly Patients (>65 Years)Diffuse Large B Cell Lymphoma (DLBCL)
Fondazione Italiana Linfomi - ETS 226
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07415980
What this trial is testing

Phase Ib/II Study of Polatuzumab Vedotin in Combination With Rituximab and Chidamide in Newly Diagnosed Elderly Patients With Double-Expressor DLBCL

Who this might be right for
Double Expressor DLBCL
Sun Yat-sen University 68
Next Page